Sweden’s Riksbank cut the policy rate this week to 3.75% (4.0%); our estimates are based on another four cuts by end-2025. During the week we upgraded Veidekke to BUY, downgraded Castellum to HOLD, and reiterated our HOLD on Kojamo and SELL on Hufvudstaden and Sagax. The average implied EBITDA yields on the stocks we cover are 4.40% for 2024e and 4.79% for 2025e.
Q3 was solid, with growth, profit and FCF driven by volume and price. The Touhula acquisition appears value-enhancing and AcadeMedia’s recent share redemption makes sense, now starting to address its track record of weak capital allocation. We see a solid demand outlook and an attractive valuation, and reiterate our BUY. We have raised our target price to SEK65 (63), still implying no near-term multiples expansion.
Q1 operating EBIT was EUR201m and Mowi proposed a DPS of NOK1.5. The Norwegian operations have suffered due to a high share of downgraded fish; however, with new vaccines, increased filleting capacity and better preparedness for jellyfish, we find a brighter outlook. Also, feed input costs have started to turn for the better, and Mowi expects lower costs in H2. We have increased our 2024–2026e EPS by 5.6–2.7%, and reiterate our BUY and NOK235 target price.
We have marginally increased our revenue estimates and revised our cost assumptions, owing to the Q1 results. With no surprises related to the Red Sea disruption or the Baltimore bridge accident, focus should shift to shareholder distributions. The revised dividend policy allows for extraordinary dividends at the board’s discretion, something we have not seen before, and the first possibility could be in connection with Q2. We calculate cNOK25/share in excess cash today, potentially on top of N...
Q1 operating EBIT of EUR201m was in line with the trading update, but 4% below consensus of EUR210m. Q2 in Norway looks better; Mowi guided for lower costs in H2 and fewer fish downgrades next winter. The 2024 volume guidance remained 500kt. The proposed DPS of NOK1.5 was below expectations of NOK1.9–2.0. Mowi sees global supply growth of 1% in 2024, strong demand in Europe and a market recovery in the Americas. We find the report neutral, and see 0–1% changes to consensus 2024e EPS, with a simi...
Mowi ASA (OSE: MOWI): Quarterly dividend The Board of Mowi ASA has resolved on 7 May 2024 to make a quarterly distribution to shareholders of NOK 1.50 per share. Mowi ASA’s shares listed on the Oslo Stock Exchange will be traded including dividend up to and including 15 May 2024. Mowi ASA’s shares listed on the Oslo Stock Exchange will be traded excluding dividend from and including 16 May 2024. Mowi ASA’s shares listed on the Oslo Stock Exchange will have a Record Date of 21 May 2024. The expected payment date is 28 May 2024. This information is subject to the disclosure requirements pur...
Mowi ASA (OSE: MOWI): Notice of Annual General Meeting 30 May 2024 Mowi ASA’s Annual General Meeting will be held on 30 May 2024 at 11:00 CET as a digital meeting. The notice including agenda for the meeting and selected appendices are attached to this disclosure. The notice will be sent today to all shareholders. The notice with complete appendices will be made available on Mowi’s website, . This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Attachment
Mowi ASA (OSE: MOWI): Innkalling til ordinær generalforsamling 30. mai 2024 Ordinær generalforsamling i Mowi ASA avholdes 30. mai 2024 kl. 11:00 som et digitalt møte. Innkalling med dagsorden til generalforsamlingen samt utvalgte vedlegg følger vedlagt. Innkallingen sendes i dag til alle aksjonærer. Innkallingen med samtlige vedlegg gjøres tilgjengelig på Mowis nettsider . Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12. Vedlegg
Good results in a biologically challenging quarter for Mowi in Norway (Bergen, 8 May 2024) Mowi recorded revenues of 1.33 billion euros in the first quarter, compared with 1.36 billion euros in the corresponding quarter of 2023. Operational profit was 201 million euros in the quarter. “The first quarter was challenging for Mowi in Norway due to winter sores and an unusually high prevalence of string jellyfish, in addition to a very cold winter. Consequently, I am pleased to see the situation in Norway has improved considerably in the second quarter. We are now vaccinating our smolt with an...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.